Tm Bioscience to supply Tag-It tests to the University of Medicine and Dentistry of New Jersey:
This article was originally published in Clinica
Executive Summary
Toronto, Canada-based diagnostics company Tm Bioscience has agreed to supply the University of Medicine and Dentistry of New Jersey (UMDNJ) with its Tag-It CTFR 40+4 mutation detection test for cystic fibrosis. The assay is developed to simultaneously screen for 25 cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and four variants as well as 15 of the world's most common and North American-prevalent mutations. UMDNJ says it plans to adopt Tm Bioscience's other tests which are available on the company's standardised genetic testing platform.